Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival

Shun Liu, Yanru Wang, William Xue, Hongliang Liu, Yinghui Xu, Qiong Shi, Wenting Wu, Dakai Zhu, Christopher I. Amos, Shenying Fang, Jeffrey E. Lee, Terry Hyslop, Yi Li, Jiali Han, Qingyi Wei

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Rho GTPases control cell division, motility, adhesion, vesicular trafficking and phagocytosis, which may affect progression and/or prognosis of cancers. Here, we investigated associations between genetic variants of Rho GTPases-related genes and cutaneous melanoma-specific survival (CMSS) by re-analyzing a published melanoma genome-wide association study (GWAS) and validating the results in another melanoma GWAS. In the single-locus analysis of 36,018 SNPs in 129 Rho-related genes, 427 SNPs were significantly associated with CMSS (p < 0.050 and false-positive report probability <0.2) in the discovery dataset, and five SNPs were replicated in the validation dataset. Among these, four SNPs (i.e., RHOU rs10916352 G > C, ARHGAP22 rs3851552 T > C, ARHGAP44 rs72635537 C > T and ARHGEF10 rs7826362 A > T) were independently predictive of CMSS (a meta-analysis derived p = 9.04 × 10−4, 9.58 × 10−4, 1.21 × 10−4 and 8.47 × 10−4, respectively). Additionally, patients with an increasing number of unfavorable genotypes (NUGs) of these loci had markedly reduced CMSS in both discovery dataset and validation dataset (ptrend=1.47 × 10−7 and 3.12 × 10−5). The model including the NUGs and clinical variables demonstrated a significant improvement in predicting the five-year CMSS. Moreover, rs10916352C and rs3851552C alleles were significantly associated with an increased mRNA expression levels of RHOU (p = 1.8 × 10−6) and ARHGAP22 (p = 5.0 × 10−6), respectively. These results may provide promising prognostic biomarkers for CM personalized management and treatment.

Original languageEnglish (US)
Pages (from-to)721-730
Number of pages10
JournalInternational Journal of Cancer
Volume141
Issue number4
DOIs
StatePublished - Aug 15 2017

Fingerprint

rho GTP-Binding Proteins
Melanoma
Skin
Survival
Genes
Genome-Wide Association Study
Single Nucleotide Polymorphism
Genotype
Phagocytosis
Cell Division
Cell Movement
Meta-Analysis
Biomarkers
Alleles
Messenger RNA

Keywords

  • cutaneous melanoma-specific survival
  • genome-wide association study
  • GTPase-activating protein
  • Rho GTPase

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival. / Liu, Shun; Wang, Yanru; Xue, William; Liu, Hongliang; Xu, Yinghui; Shi, Qiong; Wu, Wenting; Zhu, Dakai; Amos, Christopher I.; Fang, Shenying; Lee, Jeffrey E.; Hyslop, Terry; Li, Yi; Han, Jiali; Wei, Qingyi.

In: International Journal of Cancer, Vol. 141, No. 4, 15.08.2017, p. 721-730.

Research output: Contribution to journalArticle

Liu, S, Wang, Y, Xue, W, Liu, H, Xu, Y, Shi, Q, Wu, W, Zhu, D, Amos, CI, Fang, S, Lee, JE, Hyslop, T, Li, Y, Han, J & Wei, Q 2017, 'Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival', International Journal of Cancer, vol. 141, no. 4, pp. 721-730. https://doi.org/10.1002/ijc.30785
Liu, Shun ; Wang, Yanru ; Xue, William ; Liu, Hongliang ; Xu, Yinghui ; Shi, Qiong ; Wu, Wenting ; Zhu, Dakai ; Amos, Christopher I. ; Fang, Shenying ; Lee, Jeffrey E. ; Hyslop, Terry ; Li, Yi ; Han, Jiali ; Wei, Qingyi. / Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival. In: International Journal of Cancer. 2017 ; Vol. 141, No. 4. pp. 721-730.
@article{e7e45a82e6f44e4f9a8f18d8ece0e9ec,
title = "Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival",
abstract = "Rho GTPases control cell division, motility, adhesion, vesicular trafficking and phagocytosis, which may affect progression and/or prognosis of cancers. Here, we investigated associations between genetic variants of Rho GTPases-related genes and cutaneous melanoma-specific survival (CMSS) by re-analyzing a published melanoma genome-wide association study (GWAS) and validating the results in another melanoma GWAS. In the single-locus analysis of 36,018 SNPs in 129 Rho-related genes, 427 SNPs were significantly associated with CMSS (p < 0.050 and false-positive report probability <0.2) in the discovery dataset, and five SNPs were replicated in the validation dataset. Among these, four SNPs (i.e., RHOU rs10916352 G > C, ARHGAP22 rs3851552 T > C, ARHGAP44 rs72635537 C > T and ARHGEF10 rs7826362 A > T) were independently predictive of CMSS (a meta-analysis derived p = 9.04 × 10−4, 9.58 × 10−4, 1.21 × 10−4 and 8.47 × 10−4, respectively). Additionally, patients with an increasing number of unfavorable genotypes (NUGs) of these loci had markedly reduced CMSS in both discovery dataset and validation dataset (ptrend=1.47 × 10−7 and 3.12 × 10−5). The model including the NUGs and clinical variables demonstrated a significant improvement in predicting the five-year CMSS. Moreover, rs10916352C and rs3851552C alleles were significantly associated with an increased mRNA expression levels of RHOU (p = 1.8 × 10−6) and ARHGAP22 (p = 5.0 × 10−6), respectively. These results may provide promising prognostic biomarkers for CM personalized management and treatment.",
keywords = "cutaneous melanoma-specific survival, genome-wide association study, GTPase-activating protein, Rho GTPase",
author = "Shun Liu and Yanru Wang and William Xue and Hongliang Liu and Yinghui Xu and Qiong Shi and Wenting Wu and Dakai Zhu and Amos, {Christopher I.} and Shenying Fang and Lee, {Jeffrey E.} and Terry Hyslop and Yi Li and Jiali Han and Qingyi Wei",
year = "2017",
month = "8",
day = "15",
doi = "10.1002/ijc.30785",
language = "English (US)",
volume = "141",
pages = "721--730",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival

AU - Liu, Shun

AU - Wang, Yanru

AU - Xue, William

AU - Liu, Hongliang

AU - Xu, Yinghui

AU - Shi, Qiong

AU - Wu, Wenting

AU - Zhu, Dakai

AU - Amos, Christopher I.

AU - Fang, Shenying

AU - Lee, Jeffrey E.

AU - Hyslop, Terry

AU - Li, Yi

AU - Han, Jiali

AU - Wei, Qingyi

PY - 2017/8/15

Y1 - 2017/8/15

N2 - Rho GTPases control cell division, motility, adhesion, vesicular trafficking and phagocytosis, which may affect progression and/or prognosis of cancers. Here, we investigated associations between genetic variants of Rho GTPases-related genes and cutaneous melanoma-specific survival (CMSS) by re-analyzing a published melanoma genome-wide association study (GWAS) and validating the results in another melanoma GWAS. In the single-locus analysis of 36,018 SNPs in 129 Rho-related genes, 427 SNPs were significantly associated with CMSS (p < 0.050 and false-positive report probability <0.2) in the discovery dataset, and five SNPs were replicated in the validation dataset. Among these, four SNPs (i.e., RHOU rs10916352 G > C, ARHGAP22 rs3851552 T > C, ARHGAP44 rs72635537 C > T and ARHGEF10 rs7826362 A > T) were independently predictive of CMSS (a meta-analysis derived p = 9.04 × 10−4, 9.58 × 10−4, 1.21 × 10−4 and 8.47 × 10−4, respectively). Additionally, patients with an increasing number of unfavorable genotypes (NUGs) of these loci had markedly reduced CMSS in both discovery dataset and validation dataset (ptrend=1.47 × 10−7 and 3.12 × 10−5). The model including the NUGs and clinical variables demonstrated a significant improvement in predicting the five-year CMSS. Moreover, rs10916352C and rs3851552C alleles were significantly associated with an increased mRNA expression levels of RHOU (p = 1.8 × 10−6) and ARHGAP22 (p = 5.0 × 10−6), respectively. These results may provide promising prognostic biomarkers for CM personalized management and treatment.

AB - Rho GTPases control cell division, motility, adhesion, vesicular trafficking and phagocytosis, which may affect progression and/or prognosis of cancers. Here, we investigated associations between genetic variants of Rho GTPases-related genes and cutaneous melanoma-specific survival (CMSS) by re-analyzing a published melanoma genome-wide association study (GWAS) and validating the results in another melanoma GWAS. In the single-locus analysis of 36,018 SNPs in 129 Rho-related genes, 427 SNPs were significantly associated with CMSS (p < 0.050 and false-positive report probability <0.2) in the discovery dataset, and five SNPs were replicated in the validation dataset. Among these, four SNPs (i.e., RHOU rs10916352 G > C, ARHGAP22 rs3851552 T > C, ARHGAP44 rs72635537 C > T and ARHGEF10 rs7826362 A > T) were independently predictive of CMSS (a meta-analysis derived p = 9.04 × 10−4, 9.58 × 10−4, 1.21 × 10−4 and 8.47 × 10−4, respectively). Additionally, patients with an increasing number of unfavorable genotypes (NUGs) of these loci had markedly reduced CMSS in both discovery dataset and validation dataset (ptrend=1.47 × 10−7 and 3.12 × 10−5). The model including the NUGs and clinical variables demonstrated a significant improvement in predicting the five-year CMSS. Moreover, rs10916352C and rs3851552C alleles were significantly associated with an increased mRNA expression levels of RHOU (p = 1.8 × 10−6) and ARHGAP22 (p = 5.0 × 10−6), respectively. These results may provide promising prognostic biomarkers for CM personalized management and treatment.

KW - cutaneous melanoma-specific survival

KW - genome-wide association study

KW - GTPase-activating protein

KW - Rho GTPase

UR - http://www.scopus.com/inward/record.url?scp=85020071983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020071983&partnerID=8YFLogxK

U2 - 10.1002/ijc.30785

DO - 10.1002/ijc.30785

M3 - Article

C2 - 28510328

AN - SCOPUS:85020071983

VL - 141

SP - 721

EP - 730

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -